SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Collet Jean Philippe) "

Sökning: WFRF:(Collet Jean Philippe)

  • Resultat 1-10 av 29
  • [1]23Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Vieira-Silva, S., et al. (författare)
  • Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
  • 2020
  • Ingår i: Nature. - 0028-0836 .- 1476-4687. ; 581:7808, s. 310-315
  • Tidskriftsartikel (refereegranskat)abstract
    • Microbiome community typing analyses have recently identified the Bacteroides2 (Bact2) enterotype, an intestinal microbiota configuration that is associated with systemic inflammation and has a high prevalence in loose stools in humans1,2. Bact2 is characterized by a high proportion of Bacteroides, a low proportion of Faecalibacterium and low microbial cell densities1,2, and its prevalence varies from 13% in a general population cohort to as high as 78% in patients with inflammatory bowel disease2. Reported changes in stool consistency3 and inflammation status4 during the progression towards obesity and metabolic comorbidities led us to propose that these developments might similarly correlate with an increased prevalence of the potentially dysbiotic Bact2 enterotype. Here, by exploring obesity-associated microbiota alterations in the quantitative faecal metagenomes of the cross-sectional MetaCardis Body Mass Index Spectrum cohort (n = 888), we identify statin therapy as a key covariate of microbiome diversification. By focusing on a subcohort of participants that are not medicated with statins, we find that the prevalence of Bact2 correlates with body mass index, increasing from 3.90% in lean or overweight participants to 17.73% in obese participants. Systemic inflammation levels in Bact2-enterotyped individuals are higher than predicted on the basis of their obesity status, indicative of Bact2 as a dysbiotic microbiome constellation. We also observe that obesity-associated microbiota dysbiosis is negatively associated with statin treatment, resulting in a lower Bact2 prevalence of 5.88% in statin-medicated obese participants. This finding is validated in both the accompanying MetaCardis cardiovascular disease dataset (n = 282) and the independent Flemish Gut Flora Project population cohort (n = 2,345). The potential benefits of statins in this context will require further evaluation in a prospective clinical trial to ascertain whether the effect is reproducible in a randomized population and before considering their application as microbiota-modulating therapeutics. © 2020, The Author(s), under exclusive licence to Springer Nature Limited.
  •  
2.
  • Molinaro, Antonio, et al. (författare)
  • Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
  • 2020
  • Ingår i: Nature Communications. - 2041-1723. ; 11:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Microbiota-host-diet interactions contribute to the development of metabolic diseases. Imidazole propionate is a novel microbially produced metabolite from histidine, which impairs glucose metabolism. Here, we show that subjects with prediabetes and diabetes in the MetaCardis cohort from three European countries have elevated serum imidazole propionate levels. Furthermore, imidazole propionate levels were increased in subjects with low bacterial gene richness and Bacteroides 2 enterotype, which have previously been associated with obesity. The Bacteroides 2 enterotype was also associated with increased abundance of the genes involved in imidazole propionate biosynthesis from dietary histidine. Since patients and controls did not differ in their histidine dietary intake, the elevated levels of imidazole propionate in type 2 diabetes likely reflects altered microbial metabolism of histidine, rather than histidine intake per se. Thus the microbiota may contribute to type 2 diabetes by generating imidazole propionate that can modulate host inflammation and metabolism.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 29
  • [1]23Nästa
Typ av publikation
tidskriftsartikel (27)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (29)
Författare/redaktör
Collet, Jean-Philipp ... (29)
Huber, Kurt (12)
Montalescot, Gilles (12)
Roffi, Marco (11)
Storey, Robert F. (11)
Windecker, Stephan (10)
visa fler...
Bueno, Héctor (9)
Kolh, Philippe (8)
Collet, JP (7)
Jüni, Peter (7)
Valgimigli, Marco (7)
Kastrati, Adnan (7)
Tendera, Michal (6)
Zamorano, Jose Luis (6)
Halvorsen, Sigrun (6)
Merkely, Bela (6)
Hamm, Christian W. (6)
Björck, Martin (5)
Ricco, Jean-Baptiste (5)
Aboyans, Victor (5)
Brodmann, Marianne (5)
Czerny, Martin (5)
De Carlo, Marco (5)
Vlachopoulos, Charal ... (5)
Roffi, M (5)
Bueno, H (5)
Baigent, Colin (5)
Steg, Philippe Gabri ... (5)
Jeppsson, Anders, 19 ... (5)
Andreotti, Felicita (5)
Morais, Joao (5)
Patrono, Carlo (5)
Espinola-Klein, Chri ... (4)
Kahan, Thomas (4)
Kownator, Serge (4)
Mazzolai, Lucia (4)
Sprynger, Muriel (4)
Tepe, Gunnar (4)
Desormais, Ileana (4)
Tendera, M (4)
Widimsky, Petr (4)
Agewall, Stefan (4)
Knuuti, Juhani (4)
Piepoli, Massimo Fra ... (4)
Agewall, S (4)
Windecker, S (4)
Lancellotti, Patrizi ... (4)
Storey, RF (4)
Lapostolle, Frederic (4)
Mauri, Laura (4)
visa färre...
Lärosäte
Uppsala universitet (14)
Göteborgs universitet (8)
Linköpings universitet (7)
Karolinska Institutet (7)
Chalmers tekniska högskola (2)
Linnéuniversitetet (1)
Språk
Engelska (28)
Polska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (20)
Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy